-
Illinois is considering reforms to the federal 340B Drug Pricing Program. Hospitals say drugmaker restrictions are reducing funding and harming care for vulnerable and rural patients, while critics argue the program is being misused for hospital profit. Lawmakers are considering bills to increase transparency and ensure savings are directed toward lowering costs and improving access for low-income patients.